Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 118Recruiting 54Active not recruiting 37Terminated 17Unknown 16Not yet recruiting 11Withdrawn 8Enrolling by invitation 3Suspended 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Motor Activity 1Lung Neoplasms 1

Interventions

Specimen Handling 11Cyclophosphamide 9Magnetic Resonance Spectroscopy 8pembrolizumab 6Cisplatin 6Bevacizumab 6Radiosurgery 5Oxaliplatin 5Nivolumab 5Irinotecan 5Fluorouracil 5Everolimus 5Capecitabine 5venetoclax 4Vincristine 4S 1 (combination) 4Prednisone 4Leucovorin 4Etoposide 4Drug Therapy 4Doxorubicin 4Azacitidine 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Rituximab 3Radiotherapy 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × OTHER × Methods × Clear all
NCT02993068 2026-02-19

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

M.D. Anderson Cancer Center

Phase NA Suspended
5,200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT04185467 2020-04-03

Lung Cancer Rehabilitation After Medical Treatment

Nantong University

Phase NA Suspended
150 enrolled
Thoracic

Lung Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡